871507-80-1Relevant articles and documents
5-HETEROARYL-PYRIDIN-2-AMINE CONFOUNDS AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS
-
Page/Page column 55; 63-64, (2021/02/12)
The present invention relates to novel aminopyridine derivatives of the general formula (I) and pharmaceutical compositions comprising these compounds, as well as their therapeutic use, particularly as neuropeptide FF (NPFF) receptor antagonists, including, e.g., for the treatment or prevention of pain, opioid-induced hyperalgesia, or addiction.
Zirconium and hafnium complexes based on 2-aryl-8-arylaminoquinoline ligands: Synthesis, molecular structure, and catalytic performance in ethylene copolymerization
Nifant'ev, Ilya E.,Ivchenko, Pavel V.,Bagrov, Vladimir V.,Nagy, Sandor M.,Winslow, Linda N.,Merrick-Mack, Jean A.,Mihan, Shahram,Churakov, Andrei V.
supporting information, p. 1501 - 1511 (2013/02/25)
A general and efficient approach toward new zirconium and hafnium complexes based on 2-aryl-8-arylaminoquinoline ligands was developed. These precursors, when activated with MAO/borate cocatalyst and supported on silica, result in active olefin polymeriza
New tridentate cyclometalated platinum(II) and palladium(II) complexes of N,2-diphenyl-8-quinolinamine: Syntheses, crystal structures, and photophysical properties
Mao, Lisheng,Moriuchi, Toshiyuki,Sakurai, Hidehiro,Fujii, Hiroyuki,Hirao, Toshikazu
, p. 8419 - 8422 (2007/10/03)
A new tridentate cyclometalated platinum(II) complex derived from N,2-diphenyl-8-quinolinamine, which consists of two crystallographic independent molecules with two intermolecular N-H-Cl-Pt hydrogen bonds forming a dimer, exhibited a low-energy luminesce